Charterhouse invests in Phastar
Charterhouse Capital Partners has invested in biometrics clinical research organisation Phastar.
More on Buyouts
Nordic Capital launches $2bn take-over for Advanz
Advanz Pharma initially hired Jefferies to advise on a sale process in October 2020
HQIB, Cadence Growth back merger of Horn & Cosifan, PK Office
GPs intend to support a buy-and-build growth strategy for the IT service companies
Foresight sells FFX to H2 for 4.3x return
H2 focuses on mid-sized companies in the UK, Ireland and the Benelux region
Tenzing invests in MetaCompliance
MetaCompliance generated £6m in revenues in the year ending on 31 March 2020
Latest News
BGF invests more than £380m in 2020
BGF exited 20 businesses in 2020 with an average money multiple of 1.9x and an aggregate IRR of 26%
Register for the Healthcare Sector Focus virtual event
Our expert speakers will discuss the short-term impacts of Covid-19, as well as the longer-term effect on traditional healthcare infrastructure
Arcus, Aheim acquire minority stake in Milch & Zucker
Arcus could increase its share to a majority stake in future, the GP said in a statement
Maki.vc leads €1.5m round for Finnish company Calqulate
Finnish venture capitla firm Maki.vc has led a €1.5m funding round for Helsinki-based financial analytics provider Calqulate.